📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
HOMECOVERAGECBIO › EARNINGS
EARNINGS HUB
News Coverage Earnings Hub Earnings Report Grades
$CBIO
CBIO Earnings: Beat 4/4 · 4 quarters tracked
LAST 30 DAYS
2 articles
AVG GRADE
NEUTRAL
score: 0.25
SENTIMENT
TOTAL VIEWS
77
◈ EARNINGS HUB · 2026-06

CBIO Earnings: Beat, Surprise History & Forecast

4/4 quarters beaten · Last EPS $-0.74 (+8.7%) · AI Grade: NEUTRAL
◈ ESEN AI · EARNINGS PREVIEW
CBIO reported EPS of $-0.74 in its most recent quarter (2026-06), beating consensus estimate of $-0.81 by +8.7%. Over the last 4 quarters, the company has beaten estimates 4 times (100% beat rate) with an average surprise of +38.1%. ESEN AI grade: NEUTRAL.
LAST EPS
$-0.74
est $-0.81
LAST SURPRISE
+8.7%
2026-06
BEAT RATE
4/4
beats / quarters
AVG SURPRISE
+38.1%
last 4Q
◆ EPS MOMENTUM
PERIOD
ACTUAL EPS
ESTIMATE
SURPRISE
2026-06-30
$-0.74
$-0.81
+8.7%
2026-03-31
$-0.70
$-0.97
+27.5%
2025-12-31
$-0.54
$-2.57
+79.0%
2025-09-30
$-1.27
$-2.02
+37.2%
◈ RELATED EARNINGS NEWS
GlobalNewswi
2026-07-16
Cellution Biologics Inc. Signs Definitive Agreement to Acquire SimpliDerm® Human Hydrated Acellular Dermal Matrix Business from Elutia Inc., Expanding its Allograft Portfolio
LOW
manilatimes.
2026-07-16
Crescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
NEUTRAL
manilatimes.
2026-07-15
Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants
NEUTRAL
seekingalpha
2026-06-29
Crescent Biopharma: Intriguing Developer Of ADC / PD1-VEGF Assets May Not Be Sufficiently Derisked (NASDAQ:CBIO)
NEUTRAL
View all CBIO news →
◈ FREQUENTLY ASKED QUESTIONS
When did $CBIO last report earnings?
CBIO last reported earnings on 2026-06-30, with actual EPS of $-0.74 vs estimate of $-0.81.
Did $CBIO beat earnings estimates?
Yes, CBIO beat consensus EPS by +8.7% in its most recent quarter.
What is $CBIO's earnings beat rate?
CBIO has beaten consensus EPS in 4 of 4 quarters (100%). Average surprise: +38.1%.
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours. Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice